NCT06278883 2026-04-09
GRACE
Duke University
Phase NA Completed
Clinical Trials
11 trialsNCT06096779 2026-04-03
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT06600321 2026-03-31
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
Phase 1 Recruiting
NCT07377487 2026-03-30
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT05063565 2026-03-27
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT05953337 2026-03-04
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Phase NA Active not recruiting
NCT07010315 2026-03-04
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center
Recruiting
NCT05196867 2026-02-24
Liver Cancer Prevention Randomized Control Trial
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
NCT06535399 2026-01-23
Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Celgene
Phase 1 Completed